A gut microbiota rheostat forecasts responsiveness to PD-L1 and VEGF blockade in mesothelioma

August 30, 2024 | Comments Off on A gut microbiota rheostat forecasts responsiveness to PD-L1 and VEGF blockade in mesothelioma

Nature Communications 2024 August 21 [Link] Min Zhang, Aleksandra Bzura, Essa Y Baitei, Zisen Zhou, Jake B Spicer, Charlotte Poile, Jan Rogel, Amy Branson, Amy King, Shaun Barber, Tamihiro Kamata,…

Isolation and whole genomic analysis of mesophilic bacterium Pseudoglutamicibacter cumminsii in epithelial mesothelioma

August 29, 2024 | Comments Off on Isolation and whole genomic analysis of mesophilic bacterium Pseudoglutamicibacter cumminsii in epithelial mesothelioma

Heliyon 2024 August 2 [Link] Nan Xu, Kunyi Wu, Ting La, Bo Cao Abstract The relationship between bacteria and tumors has been the hot spot of clinical research in recent…

Unleashing precision: A review of targeted approaches in pleural mesothelioma

August 28, 2024 | Comments Off on Unleashing precision: A review of targeted approaches in pleural mesothelioma

Critical Reviews in Oncology and Hematology 2024 August 17 [Link] Mario Occhipinti, Marta Brambilla, Raimondo Di Liello, Paolo Ambrosini, Lorenzo Lobianco, Rita Leporati, Maria Salvarezza, Fabiana Vitiello, Silvia Marchesi, Sara…

Case report: ATM A1159T mutation in malignant peritoneal mesothelioma may be associated with tumor recurrence

August 27, 2024 | Comments Off on Case report: ATM A1159T mutation in malignant peritoneal mesothelioma may be associated with tumor recurrence

SAGE Open Medical Case Reports 2024 August 16 [Link] Ying Li, Jintao Yang, Bei Zheng, Na Yan, Wenjuan Yang, Xinling Xie, Guoshu Xu, Meiling Zhang Abstract Malignant peritoneal mesothelioma is…

Volatile Organic Compound Analysis of Malignant Pleural Mesothelioma Chorioallantoic Membrane Xenografts

August 26, 2024 | Comments Off on Volatile Organic Compound Analysis of Malignant Pleural Mesothelioma Chorioallantoic Membrane Xenografts

Journal of Breath Research 2024 August 20 [Link] Liam David Little, Sarah E Barnett, Theo Issitt, Sam Bonsall, Vikki Amanda Carolan, K Elizabeth Allen, Laura Margaret Cole, Neil A Cross,…

Stemness and hybrid epithelial-mesenchymal profiles guide peritoneal dissemination of malignant mesothelioma and pseudomyxoma peritonei

August 22, 2024 | Comments Off on Stemness and hybrid epithelial-mesenchymal profiles guide peritoneal dissemination of malignant mesothelioma and pseudomyxoma peritonei

International Journal of Cancer 2024 August 15 [Link] Nayana Lazzari, Giulia Rigotto, Barbara Montini, Paola Del Bianco, Elena Moretto, Federica Palladino, Rocco Cappellesso, Marco Tonello, Carola Cenzi, Antonio Scapinello Maria…

Pleural fluid biomarkers: a narrative review

August 21, 2024 | Comments Off on Pleural fluid biomarkers: a narrative review

Journal of Thoracic Disease 2024 July 30 [Link] Christopher Chan, Ken Ka Pang Chan Abstract Background and objective: Pleural fluid is a source from which various biomarkers can be obtained…

Outcome prediction based on [18F]FDG PET/CT in patients with pleural mesothelioma treated with ipilimumab and nivolumab +/- UV1 telomerase vaccine

August 20, 2024 | Comments Off on Outcome prediction based on [18F]FDG PET/CT in patients with pleural mesothelioma treated with ipilimumab and nivolumab +/- UV1 telomerase vaccine

European Journal of Nuclear Medicine and Molecular Imaging 2024 August 12 [Link] Solfrid Thunold, Eivor Hernes, Saima Farooqi, Åsa Kristina Öjlert, Roslyn J Francis, Anna K Nowak, Weronika Maria Szejniuk,…

Peritoneal Dissemination in Patients with Recurrence After Post-pleurectomy/decortication for Pleural Mesothelioma

August 19, 2024 | Comments Off on Peritoneal Dissemination in Patients with Recurrence After Post-pleurectomy/decortication for Pleural Mesothelioma

Annals of Surgical Oncology 2024 August 10 [Link] Akifumi Nakamura, Masaki Hashimoto, Ayumi Kuroda, Kyoshiro Takegahara, Akihiro Fukuda, Seiji Matsumoto, Nobuyuki Kondo, Toshiyuki Minami, Kazuhiro Kitajima, Kozo Kuribayashi, Takashi Kijima,…

Comparison of First-Line Chemotherapeutics and Validation of the EORTC Prognostic Index in Malignant Pleural Mesothelioma: Retrospective Single-Centre Experience

August 16, 2024 | Comments Off on Comparison of First-Line Chemotherapeutics and Validation of the EORTC Prognostic Index in Malignant Pleural Mesothelioma: Retrospective Single-Centre Experience

Journal of the College of Physicians and Surgeons 2024 August [Link] Yasin Sezgin, Ogur Karhan, Serdar Ileri, Senar Ebinc, Sezai Tunc, Zuhat Urakci Abstract Objective: To evaluate the efficiency of…

Categories